Glucarpidase Market Analysis by Type of Application (Methotrexate Toxicity, Other Applications), By Formulation (Injectable, Others), By End-User (Hospitals, Specialty Clinics, Research and Academic Institutes) and by Region: Global Forecast, 2024 - 2034.
- PUBLISHED ON
- 2024-08-09
- NO OF PAGES
- 310
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Glucarpidase market is predicted to
develop at a compound annual growth rate (CAGR) of xx from
2024 to 2034, when it is projected to reach USD xx Billion, based on an average
growth pattern. The market is estimated to reach a value of USD xx Billion in
2024.
SOURCE: We Market Research
An enzyme called
glucarpidase is used to alleviate methotrexate toxicity, particularly in those
with reduced kidney function. It functions by dissolving methotrexate into
inert metabolites that the body can quickly get rid of. When glucarpidase is
injected intravenously, methotrexate levels are quickly lowered, lessening the
medication's harmful effects. Hypotension, nausea, and allergic reactions are
typical side effects. Patients taking leucovorin, a medication that is
frequently taken with methotrexate, need to be closely watched for potential
interactions since glucarpidase can reduce the drug's efficacy. When taking
both medications, timing and administration must be done correctly.
Rising cancer rates that require high-dose methotrexate therapy, growing knowledge and detection of methotrexate toxicity, and improvements in enzyme production due to biotechnology developments are the main factors driving the global glucarpidase market. Expanding healthcare infrastructure in developing nations and supportive regulatory regimes also boost industry expansion. Furthermore, there is a growing need for glucarpidase due to an aging global population that is more susceptible to cancer and its therapies. When used to treat methotrexate toxicity, these variables increase the demand for and supply of glucarpidase on a worldwide scale.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD xx Billion |
|
Market
Forecast in 2034 |
USD xx Billion |
|
CAGR % 2024-2034 |
xx% |
|
Base
Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast
Period |
2024-2034 |
|
Report USP
|
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
|
Segments
Covered |
By Type of
Application, By Formulation, By End-User and By Region |
|
Regional Scope |
North America,
Europe, APAC, South America and Middle East and Africa |
|
Country
Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Glucarpidase Industry: Dynamics & Restrains
Market opportunity:
We Market
Research: Glucarpidase Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Glucarpidase Segmentation
Market- By Type of Application Analysis
By Type of Application, the Glucarpidase Market is Categories into Methotrexate Toxicity, Other Applications. The Methotrexate Toxicity segment accounts for the largest share of around 90% in 2024.
The driver for Methotrexate Toxicity in the
Global Glucarpidase Market is the increasing prevalence of high-dose
methotrexate use in cancer treatments, leading to a higher incidence of
toxicity and a growing demand for effective detoxification solutions.
The
following segments are part of an in-depth analysis of the global Glucarpidase
market:
|
Market
Segments |
|
|
By
Formulation |
·
Injectable ·
Others |
|
By
End-User |
·
Hospitals ·
Specialty Clinics ·
Research and Academic Institutes |
Glucarpidase Industry: Regional Analysis
North America Market Forecast
North America dominates the Glucarpidase Market with the highest revenue generating market with share of more than 46%. The glucarpidase market in North America benefits from advanced healthcare infrastructure, high cancer rates, and significant investments in biotechnology. The U.S. and Canada have established protocols for managing methotrexate toxicity, leading to high market demand. Awareness among healthcare providers and patients further supports market growth, making this region a leader in the glucarpidase market.
Europe Market Statistics
In Europe, the
glucarpidase market is driven by robust healthcare systems, high cancer
incidence, and favorable regulatory frameworks. Countries like Germany, France,
and the UK have strong treatment protocols and high awareness, contributing to
significant market development. The region's supportive environment for
biotechnology and pharmaceuticals enhances glucarpidase adoption.
Asia Pacific Market Forecasts
Asia Pacific is expected to be the fastest-growing regional segment of the Glucarpidase market during the forecast period. The Asia-Pacific region shows significant market potential due to rising cancer rates, expanding healthcare infrastructure, and growing awareness about methotrexate toxicity. China and India are key contributors, with increased investment in healthcare and treatment facilities. However, challenges such as high treatment costs and limited access in some areas can impact market growth.
Key Market Players
·
SERB Pharmaceuticals
1.
Global
Glucarpidase Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Glucarpidase Market Scope
and Market Estimation
1.2.1. Global Glucarpidase Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Glucarpidase Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Type of Application of Global Glucarpidase
Market
1.3.2. Formulation of Global Glucarpidase
Market
1.3.3. End-user of Global Glucarpidase
Market
1.3.4. Region of Global Glucarpidase
Market
2.
Executive Summary
2.1. Market Dynamics
2.1.1. Drivers
2.1.2. Limitations
2.1.3. Opportunities
2.1.4. Impact Analysis of Drivers and
Restraints
2.2. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.3. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitutes
2.4.4. Threat of New Entrants
2.4.5. Competitive Rivalry
2.5. Value Chain / Ecosystem Analysis
2.6. Russia-Ukraine War Impacts
Analysis
2.7. Economic Downturn Analysis
2.8. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Glucarpidase Market Estimates & Historical Trend Analysis (2019 -
2023)
4.
Global Glucarpidase Market Estimates & Forecast Trend Analysis, by
Type of Application
4.1. Global Glucarpidase Market
Revenue (US$ Mn) Estimates and Forecasts, by Type of Application, 2019 to 2034
4.1.1. Methotrexate Toxicity
4.1.2. Other Applications
5.
Global Glucarpidase Market Estimates & Forecast Trend Analysis, by
Formulation
5.1. Global Glucarpidase Market
Revenue (US$ Mn) Estimates and Forecasts, by Formulation, 2019 to 2034
5.1.1. Injectable
5.1.2. Others
6.
Global Glucarpidase Market Estimates & Forecast Trend Analysis, by
End-user
6.1. Global Glucarpidase Market
Revenue (US$ Mn) Estimates and Forecasts, by End-user,
2019 to 2034
6.1.1. Hospitals
6.1.2. Specialty Clinics
6.1.3. Research and Academic Institutes
7.
Global Glucarpidase Market Estimates & Forecast Trend Analysis,
by region
7.1. Global Glucarpidase Market
Revenue (US$ Mn) Estimates and Forecasts, by region, 2019 to 2034
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.
North
America Glucarpidase Market: Estimates & Forecast Trend Analysis
8.1.
North
America Glucarpidase Market Assessments & Key Findings
8.1.1. North America Glucarpidase
Market Introduction
8.1.2. North America Glucarpidase
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
8.1.2.1. By Type of
Application
8.1.2.2. By Formulation
8.1.2.3. By End-user
8.1.2.4. By Country
8.1.2.4.1. The U.S.
8.1.2.4.2. Canada
8.1.2.4.3. Mexico
9.
Europe
Glucarpidase Market: Estimates & Forecast Trend Analysis
9.1. Europe Glucarpidase Market
Assessments & Key Findings
9.1.1. Europe Glucarpidase Market
Introduction
9.1.2. Europe Glucarpidase Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1. By Type of
Application
9.1.2.2. By Formulation
9.1.2.3. By End-user
9.1.2.4.
By
Country
9.1.2.4.1. Germany
9.1.2.4.2. U.K.
9.1.2.4.3. France
9.1.2.4.4. Italy
9.1.2.4.5. Spain
9.1.2.4.6. Russia
9.1.2.4.7. Rest of Europe
10. Asia Pacific Glucarpidase
Market: Estimates & Forecast Trend
Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1. Asia Pacific Glucarpidase Market
Introduction
10.1.2. Asia Pacific Glucarpidase Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1. By Type of
Application
10.1.2.2. By Formulation
10.1.2.3. By End-user
10.1.2.4. By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Glucarpidase
Market: Estimates & Forecast Trend
Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1. Middle
East & Africa Glucarpidase
Market Introduction
11.1.2. Middle
East & Africa Glucarpidase
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1. By Type of
Application
11.1.2.2. By Formulation
11.1.2.3. By End-user
11.1.2.4. By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Glucarpidase Market: Estimates &
Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1. South America Glucarpidase
Market Introduction
12.1.2. South America Glucarpidase
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1. By Type of
Application
12.1.2.2. By Formulation
12.1.2.3. By End-user
12.1.2.4. By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Glucarpidase Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Glucarpidase Market
Competition White Space Analysis, By End-user
13.3. Global Glucarpidase Market
Competition Heat Map Analysis, By End-user
13.4. Global Glucarpidase Market
Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.
SERB Pharmaceuticals
14.1.1. Company Overview & Key Stats
14.1.2. Financial Performance & KPIs
14.1.3. Product Portfolio
14.1.4. Business Strategy & Recent
Developments
15. Research
Methodology
15.1. External Transportations /
Databases
15.2. Internal Proprietary Database
15.3. Primary Research
15.4. Secondary Research
15.5. Assumptions
15.6. Limitations
15.7. Report FAQs
16. Research
Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the growth rate for the Glucarpidase Market?
Glucarpidase Market size will increase at approximate CAGR of xx% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Glucarpidase Market is SERB Pharmaceuticals.
Which region dominates the Glucarpidase Market?
North America dominates the market with an active share of 46%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI